<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Sinus node dysfunction: Epidemiology, etiology, and natural history
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Sinus node dysfunction: Epidemiology, etiology, and natural history
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Sinus node dysfunction: Epidemiology, etiology, and natural history
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Munther K Homoud, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Samuel Lévy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan B Yeon, MD, JD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 08, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The sinoatrial (SA) node is normally the dominant pacemaker in the human heart. Originally described in 1907 as a subepicardial structure located at the junction of the right atrium and superior vena cava, the SA node represents the integrated activity of pacemaker cells in a compact region of the right atrium that depolarize and produce action potentials almost synchronously [
         <a href="#rid1">
          1-3
         </a>
         ]. While the location of the primary pacemaker may move among groups of cells within the region of the SA node, only about 1 percent of the cells in the SA node act as the leading pacemaker [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Sinus node dysfunction (SND), also historically referred to as sick sinus syndrome, is the term used to describe the inability of the SA node to generate a heart rate that meets the physiologic needs of an individual. The initial clues to the diagnosis of SND are often derived from taking the history and obtaining a routine electrocardiogram (ECG), though the symptoms and ECG findings are frequently vague and nonspecific. The diagnostic evaluation should initially include a search for remediable causes of SA nodal depression such as drugs (eg, beta blockers, calcium channel blockers,
         <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">
          digoxin
         </a>
         ) and metabolic diseases (eg, hypothyroidism). Treatment of SND is directed at symptoms and typically involves the implantation of a permanent pacemaker.
        </p>
        <p>
         The epidemiology, potential etiologies, and the natural history of SND will be reviewed here. The clinical manifestations, approach to diagnosis, and the treatment of SND are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/896.html" rel="external">
          "Sinus node dysfunction: Clinical manifestations, diagnosis, and evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1072.html" rel="external">
          "Sinus node dysfunction: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20741334">
         <span class="h1">
          NORMAL PHYSIOLOGY OF THE SA NODE
         </span>
        </p>
        <p class="headingAnchor" id="H440351940">
         <span class="h2">
          Cellular physiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pacemaking activity that originates from the sinoatrial (SA) node is incompletely understood. There are two predominant mechanisms that are thought to serve as the initiation of sinus activity:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The funny current (I
         <sub>
          f
         </sub>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spontaneous intracellular calcium release by sarcoplasmic reticulum
        </p>
        <p>
        </p>
        <p>
         The I
         <sub>
          f
         </sub>
         current is the result of sodium and potassium ionic currents that allow for a steady increase in the resting membrane potential of the cell  (
         <a class="graphic graphic_figure graphicRef70771" href="/z/d/graphic/70771.html" rel="external">
          figure 1
         </a>
         ). Once the resting membrane reaches the depolarization threshold of the cell, an action potential is generated, and electrical activity ensues. The rate of the steady increase of the resting membrane potential can be modulated by other ionic currents as well as beta-adrenergic activity. As the slope of the increase in resting membrane potential steepens, the rate of spontaneous sinus node activity increases.
        </p>
        <p>
         The second mechanism thought to be critical in SA node activity initiation is spontaneous sarcoplasmic reticulum calcium release within the SA nodal cells [
         <a href="#rid5">
          5
         </a>
         ]. The release of calcium into the intracellular space results in activation of the sodium-calcium exchange current, eventually leading to phase 4 depolarization. These two mechanisms are not mutually exclusive, and evidence suggests that they may be complementary in their pacemaking actions. (See
         <a class="medical medical_review" href="/z/d/html/895.html" rel="external">
          "Cardiac excitability, mechanisms of arrhythmia, and action of antiarrhythmic drugs", section on 'Action potential in slow response tissues'
         </a>
         .)
        </p>
        <p>
         While the calcium and potassium currents are the predominant determinants of SA nodal automaticity, there is evidence to suggest that the sodium channel may also play a role. Mutations in the human cardiac sodium channel (
         <em>
          SCN5A
         </em>
         ) cause one type of long-QT syndrome (LQT3), and these individuals may also have sinus pauses and sinus bradycardia in addition to the characteristic prolongation of the QT interval. Studies in cells expressing either wild type or LQT3 channels showed that an increase in a persistent inward current in the mutated channels reduced the sinus rate directly and could also result in the failure to repolarize completely [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">
          "Congenital long QT syndrome: Pathophysiology and genetics", section on 'Type 3 LQTS (LQT3)'
         </a>
         .)
        </p>
        <p>
         As mentioned above, pacemaking can originate from different areas within the sinus node. Mapping of sinus node activation indicates that at faster rates, the SA impulse originates in the superior portion of the SA node, or extranodally, while at slower rates, it arises from the inferior portion of the node or, once again, extranodally [
         <a href="#rid7">
          7
         </a>
         ]. The SA node may be insulated from the surrounding atrial myocytes except at a limited number of preferential exit sites. Shifting pacemaker sites may select different exit pathways to the atria.
        </p>
        <p class="headingAnchor" id="H20741346">
         <span class="h2">
          Autonomic nervous system and the SA node
         </span>
         <span class="headingEndMark">
          —
         </span>
         The SA node is innervated by the parasympathetic and the sympathetic nervous systems, and the balance between these systems controls the pacemaker rate. The classic concept has been that of a reciprocally balanced relationship between sympathetic and parasympathetic inputs. More recent investigations, however, stress dynamic, demand-oriented interactions and the anatomic distribution of fibers that allows both autonomic systems to act quite selectively [
         <a href="#rid8">
          8
         </a>
         ]. Muscarinic cholinergic and beta-1 adrenergic receptors are nonuniformly distributed in the SA node and modulate both the rate of depolarization and propagation [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20741352">
         <span class="h3">
          Parasympathetic activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Parasympathetic input via the vagus nerves
         <strong>
          decreases
         </strong>
         the SA nodal pacemaker and is the dominant input at rest. The mediator of parasympathetic activity is acetylcholine (ACh) which, as a ligand gating agent, acts through the G-protein, G
         <sub>
          i
         </sub>
         , to activate a certain group of membrane channels called I
         <sub>
          KACh
         </sub>
         channels  (
         <a class="graphic graphic_figure graphicRef70771" href="/z/d/graphic/70771.html" rel="external">
          figure 1
         </a>
         ) in tissues of the SA and atrioventricular (AV) nodes as well as of the atria, Purkinje fibers, and ventricles [
         <a href="#rid9">
          9
         </a>
         ]. Acetylcholine increases the outward potassium current, thereby slowing the SA nodal pacemaker, by at least two important mechanisms:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The resting potential and the maximum diastolic potential become more negative; as a result, more current is required to reach threshold.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The outward potassium current opposes the inward currents responsible for depolarizing the cell, resulting in a decrease in phase 4 depolarization.
        </p>
        <p>
        </p>
        <p>
         Acetylcholine also reduces the inward calcium current, I
         <sub>
          Ca
         </sub>
         through the G-protein system.
        </p>
        <p class="headingAnchor" id="H20741358">
         <span class="h3">
          Sympathetic activity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sympathetic nerve input, as well as the adrenal medullary release of catecholamines,
         <strong>
          increases
         </strong>
         the sinus rate during exercise and stress. The manner in which beta-receptor stimulation by catecholamines affects automaticity is complex and involves interactions of the beta-receptor/adenylate cyclase/G-protein systems. Catecholamines enhance the L-type of inward calcium current by increasing cyclic adenosine monophosphate (AMP) and activating the protein kinase A system; the increment in inward calcium current would be expected to increase the rate of phase 4 diastolic depolarization. The redistribution of calcium may also increase the completeness and the rate of I
         <sub>
          K
         </sub>
         deactivation. Catecholamines may also enhance I
         <sub>
          f
         </sub>
         .
        </p>
        <p class="headingAnchor" id="H440352043">
         <span class="h2">
          SA nodal remodeling
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atrial tachyarrhythmias can cause persistent changes in atrial electrophysiology that result in increased vulnerability to further dysrhythmia. This phenomenon is called "atrial remodeling." (See
         <a class="medical medical_review" href="/z/d/html/16402.html" rel="external">
          "Mechanisms of atrial fibrillation", section on 'Electrical remodeling'
         </a>
         .)
        </p>
        <p>
         The SA node may also undergo electrophysiologic changes in response to atrial arrhythmias or other stimuli (see bullets below); these changes result in SA node dysfunction and are referred to as "SA nodal remodeling" [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p>
         Remodeling of the SA node may also occur in the setting of heart failure, even in the absence of a history of atrial fibrillation [
         <a href="#rid12">
          12
         </a>
         ]. In a study of 18 patients with symptomatic heart failure and 18 age-matched controls, those with heart failure had significant prolongation of the intrinsic sinus cycle length, corrected sinus node recovery time, and sinoatrial conduction time, as well as caudal displacement of sinus activity and an increase in the number and duration of fractionated atrial electrograms [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         After ablation for atrial fibrillation, reverse remodeling of the SA node may occur with elimination of the SA node depression and the prolonged sinus pauses [
         <a href="#rid14">
          14
         </a>
         ]. Reverse remodeling of SA nodal function also occurs after the termination of atrial flutter [
         <a href="#rid15">
          15
         </a>
         ] and after the catheter ablation of right atrial flutter [
         <a href="#rid16">
          16
         </a>
         ]. As little as 10 to 15 minutes of atrial pacing causes SA nodal remodeling in humans [
         <a href="#rid17">
          17
         </a>
         ]. Interestingly, asynchronous ventricular pacing has also been associated with SA nodal remodeling [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H440353214">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sinus node dysfunction (SND) is characterized by dysfunction of the sinoatrial (SA) node that is often secondary to senescence of the node and surrounding atrial myocardium. The term "sinus node dysfunction" was first used in 1967 to describe the sluggish return of SA nodal activity in some patients following electrical cardioversion and is now commonly used to describe the inability of the SA node to generate a heart rate that meets the physiologic needs of an individual [
         <a href="#rid19">
          19-21
         </a>
         ]. SND can present with numerous ECG abnormalities including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sinus bradycardia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sinus pauses
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sinus arrest
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SA nodal exit block
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inadequate heart rate response to physiological demands during activity (chronotropic incompetence)
        </p>
        <p>
        </p>
        <p>
         SND can also be accompanied by supraventricular tachycardias (atrial fibrillation, atrial flutter, and atrial tachycardia) as part of the tachycardia-bradycardia syndrome. (See
         <a class="medical medical_review" href="/z/d/html/896.html" rel="external">
          "Sinus node dysfunction: Clinical manifestations, diagnosis, and evaluation", section on 'ECG findings'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H440352271">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The epidemiology of SND is difficult to study, given the nature of SND and its varying manifestations, including nonspecific symptoms and ECG findings. However, patients with symptomatic SND are generally older (ie, seventh or eighth decade of life) with frequent comorbid diseases.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a pooled analysis of 20,572 patients from two large epidemiology studies (Atherosclerosis Risk in Communities [ARIC] and Cardiovascular Health Study [CHS]) who were followed for an average of 17 years, 291 incident cases of SND were noted, yielding in an incidence rate of 0.8 cases per 1000 person-years [
         <a href="#rid22">
          22
         </a>
         ]. While several variables were associated with development of SND (eg, higher body mass index, hypertension, prior cardiovascular event), advancing age was the most significant risk factor for SND (hazard ratio 1.73 for each additional five years of age; 95% CI 1.47-2.05).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In three major trials of pacing in this disorder, the median or mean age was 73 to 76 years [
         <a href="#rid23">
          23-25
         </a>
         ]. Males and females appear equally affected, and although less common, SND can occur in younger adults and children. (See
         <a class="local">
          'Childhood and familial disease'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sinoatrial (SA) node dysfunction occurs as a result of disorders in automaticity, conduction, or both. Local cardiac pathology, systemic diseases that involve the heart, and medications/toxins can all be responsible for abnormal SA node function and result in SND.
        </p>
        <p>
         Most cases of sinus node dysfunction entail extrinsic and intrinsic components. Identification of an extrinsic component is important because it is often modifiable. Drug-induced SND (suppression) is transient and modifiable, whereas SND due to an infiltrative cardiomyopathy, surgical intervention, or a mutation in a number of genes identified to be associated with SND is not. Thus, it is important to identify and eliminate any aggravating (reversible) factors causing SND, given the absence of treatment of intrinsic SND other than pacemaker therapy with its associated limitations. (See
         <a class="medical medical_review" href="/z/d/html/1072.html" rel="external">
          "Sinus node dysfunction: Treatment"
         </a>
         .)
        </p>
        <p>
         Abnormal automaticity, or sinus arrest, refers to a failure of sinus impulse generation. Abnormal conduction, or sinoatrial delay or block, is a failure of impulse transmission. In such cases, the sinus impulse is generated normally, but it is abnormally conducted to the neighboring atrial tissue. Both abnormal automaticity and abnormal conduction may result from one of several different mechanisms including fibrosis, atherosclerosis, and inflammatory/infiltrative myocardial processes.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Sinus node fibrosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common cause of sinus node dysfunction is the replacement of sinus node tissue by fibrous tissue, which may be accompanied by degeneration and fibrosis of other parts of the conduction system as well, including the atrioventricular (AV) node [
         <a href="#rid26">
          26-28
         </a>
         ]. The transitional junction between the sinus node and atrial tissue may also be involved, and there may be degeneration of nerve ganglia.
        </p>
        <p class="headingAnchor" id="H440349509">
         <span class="h2">
          Medications and toxins
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of medications and toxins can reversibly depress sinus node function, resulting in symptoms and ECG changes consistent with SND. The most commonly used prescription medications which alter myocardial conduction and can potentially result in SND include [
         <a href="#rid29">
          29-34
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beta blockers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nondihydropyridine calcium channel blockers
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">
          Digoxin
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antiarrhythmic medications
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acetylcholinesterase inhibitors such as
         <a class="drug drug_general" data-topicid="9383" href="/z/d/drug information/9383.html" rel="external">
          donepezil
         </a>
         (Aricept) and
         <a class="drug drug_general" data-topicid="9529" href="/z/d/drug information/9529.html" rel="external">
          rivastigmine
         </a>
         used in the treatment of Alzheimer disease
        </p>
        <p>
        </p>
        <p>
         Other medications associated with depression of sinus node function include parasympathomimetic agents, sympatholytic drugs (eg,
         <a class="drug drug_general" data-topicid="9635" href="/z/d/drug information/9635.html" rel="external">
          methyldopa
         </a>
         ,
         <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">
          clonidine
         </a>
         ),
         <a class="drug drug_general" data-topicid="9265" href="/z/d/drug information/9265.html" rel="external">
          cimetidine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">
          lithium
         </a>
         , and
         <a class="drug drug_general" data-topicid="101166" href="/z/d/drug information/101166.html" rel="external">
          ivabradine
         </a>
         [
         <a href="#rid35">
          35,36
         </a>
         ]. In addition, poisoning by grayanotoxin, produced by some plants (eg,
         <em>
          Rhododendron sp.
         </em>
         ) and found in certain varieties of honey, has been associated with depressed sinus node function [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6106301">
         <span class="h2">
          Childhood and familial disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         SND is rare in children, but when present it is most often seen in those with congenital and acquired heart disease, particularly after corrective cardiac surgery [
         <a href="#rid38">
          38-41
         </a>
         ]. Familial sinus node dysfunction is rare, with mutations in the cardiac sodium channel gene
         <em>
          SCN5A
         </em>
         and the
         <em>
          HCN4
         </em>
         gene (thought to contribute to the pacemaker current in the sinus node) responsible for some familial cases [
         <a href="#rid42">
          42-48
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a series of 30 children and young adults (ages 3 days to 25 years) with sinus node dysfunction, 22 had significant cardiac disease, and sinus node dysfunction developed after cardiac surgery in 13 [
         <a href="#rid38">
          38
         </a>
         ]. The causes of sinus node dysfunction were inappropriate sinus bradycardia, sinus arrest, and sinoatrial exit block.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a study of 10 children from seven families with familial SND, genomic DNA encoding the alpha subunit of the cardiac sodium channel was screened for mutations [
         <a href="#rid42">
          42
         </a>
         ]. Compound heterozygous nucleotide changes were identified in five children from three families (but in none of over 75 control subjects).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a series of 38 patients with clinical evidence of Brugada syndrome, four had
         <em>
          SCN5A
         </em>
         mutations [
         <a href="#rid45">
          45
         </a>
         ]. Three of these patients had SND with multiple affected family members. Mutations in
         <em>
          SCN5A
         </em>
         are not pathognomonic for sinus node disease, however, as different
         <em>
          SCN5A
         </em>
         mutations are associated with other cardiac abnormalities including Brugada syndrome, congenital long QT syndrome type 3, familial AV block, and familial dilated cardiomyopathy with conduction defects and susceptibility to atrial fibrillation (AF). (See
         <a class="medical medical_review" href="/z/d/html/1009.html" rel="external">
          "Congenital long QT syndrome: Pathophysiology and genetics"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/907.html" rel="external">
          "Etiology of atrioventricular block"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4911.html" rel="external">
          "Genetics of dilated cardiomyopathy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1020.html" rel="external">
          "Brugada syndrome: Epidemiology and pathogenesis", section on 'SCN5A'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mutations in
         <em>
          HCN4
         </em>
         can produce both symptomatic and asymptomatic sinus node dysfunction, as illustrated by numerous reports of sinus bradycardia in family members with such mutations [
         <a href="#rid46">
          46-49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H440351002">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         SND is less often due to a variety of other disorders:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infiltrative diseases – The SA node may be affected by infiltrative disease, such as amyloidosis, sarcoidosis, scleroderma [
         <a href="#rid50">
          50
         </a>
         ], hemochromatosis, and rarely tumor.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inflammatory diseases – Rheumatic fever, pericarditis, diphtheria, Chagas disease, and other disorders may depress SA nodal function.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SA nodal artery disease – The sinus node is perfused by branches of the right coronary artery in 55 to 60 percent and by the left circumflex artery in the remaining 40 to 45 percent. The SA nodal artery may be narrowed by atherosclerosis, inflammatory processes, or even emboli [
         <a href="#rid28">
          28,50-52
         </a>
         ]. Approximately 5 percent of patients with myocardial infarction, usually inferior, show sinus node dysfunction that tends to be reversible [
         <a href="#rid53">
          53-55
         </a>
         ]. In one study of 46 patients with prior inferior myocardial infarction (23 patients with and 23 without SND), the intrinsic heart rate was abnormal in almost all patients with more than a 75 percent narrowing of the SA nodal artery, but only 30 percent with less than 50 percent narrowing [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Trauma – Cardiac trauma during surgery may affect either the SA node directly or its blood supply.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Miscellaneous – Other disorders that can cause SND include hypothyroidism, hypothermia, hypoxia, and muscular dystrophies. Some infections (eg, leptospirosis, trichinosis, and Salmonella typhosa) are associated with relative sinus bradycardia, but permanent SND has not followed these [
         <a href="#rid57">
          57-60
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          NATURAL HISTORY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The natural history of SND typically involves intermittent but progressive cardiac rhythm disorders, which have been associated with higher rates of other cardiovascular events and higher mortality. There is a tendency for the rhythm disturbances associated with SND to evolve over time, along with a higher likelihood of thromboembolic events and other cardiovascular events.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Rhythm
         </span>
         <span class="headingEndMark">
          —
         </span>
         For many patients with SND, there are variable, and often long, periods of normal sinus node function [
         <a href="#rid61">
          61
         </a>
         ]. Nevertheless, once present, sinus node dysfunction eventually progresses in most patients, along with a greater likelihood of developing atrial tachyarrhythmias [
         <a href="#rid62">
          62
         </a>
         ]. However, it is very difficult to predict the time course of disease progression, which is why most patients with symptomatic SND will be treated earlier in an attempt to alleviate symptoms. (See
         <a class="medical medical_review" href="/z/d/html/1072.html" rel="external">
          "Sinus node dysfunction: Treatment"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sinus node dysfunction progresses over time. In one cohort of 52 patients with sinus node dysfunction who presented with sinus bradycardia associated with sinoatrial (SA) block or SA arrest, it took an average of 13 years (range 7 to 29 years) for progression to complete SA arrest and an escape rhythm [
         <a href="#rid61">
          61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Atrial arrhythmias and conduction disturbances become more common over time, possibly the result of a progressive pathological process that affects the entire atrium and other parts of the heart [
         <a href="#rid27">
          27,63,64
         </a>
         ]. As an example, among 213 patients with a history of symptomatic SND who were treated with atrial pacing and followed for a median of five years, 7 percent developed atrial fibrillation and 8.5 percent developed high-grade atrioventricular block [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Cardiovascular events
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with SND, particularly those with alternating tachycardia and bradycardia, are at an increased risk for thromboembolic events even after pacemaker implantation. A possible contributor to cardiovascular events after pacemaker implantation is asymptomatic episodes of atrial fibrillation resulting in thromboembolic events. (See
         <a class="medical medical_review" href="/z/d/html/1031.html" rel="external">
          "Atrial fibrillation in adults: Use of oral anticoagulants"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In one prospectively-followed cohort of 35 patients aged ≥45 years with symptomatic SND manifested by a mean sinus rate at rest ≤50 beats/minute and/or intermittent SA block, who did not undergo immediate treatment but were followed for an average of 17 months, a cardiovascular event requiring treatment occurred in 57 percent of patients and included syncope (23 percent), overt heart failure (17 percent), chronic atrial fibrillation (11 percent), or poorly tolerated atrial arrhythmias (6 percent) [
         <a href="#rid66">
          66
         </a>
         ]. Independent predictors of a cardiovascular event were age, left ventricular end-diastolic diameter, and left ventricular ejection fraction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a study of 225 patients with SND who were randomized to single-chamber atrial or ventricular pacing, the annual risk of thromboembolism was approximately twofold higher for patients with SND and tachycardia/bradycardia syndrome compared with patients without tachycardia/bradycardia syndrome [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         The relationship between SND and mortality is difficult to clearly understand as many individuals with SND have pre-existing comorbidities (hypertension, diabetes mellitus, atrial fibrillation) that are known to increase all-cause mortality. In one study of 19,893 persons from two prospective cohorts without atrial fibrillation or a pacemaker at baseline who were followed for an average of 17 years, 213 persons developed SND (0.6 events per 1000 person-years) [
         <a href="#rid68">
          68
         </a>
         ]. While the development of SND was associated with a significantly higher mortality, this association was attenuated following adjustment for incident cardiovascular disease during follow-up. While SND certainly contributes to patient morbidity, if or how SND increases overall mortality is unclear.
        </p>
        <p class="headingAnchor" id="H17478080">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/82824.html" rel="external">
          "Patient education: Sinus node dysfunction (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16936.html" rel="external">
          "Patient education: Bradycardia (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6105633">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physiology of the SA node
         </strong>
         – The sinoatrial (SA) node is innervated by the parasympathetic and the sympathetic nervous systems, and the balance between these systems controls the pacemaker rate. Parasympathetic input via the vagus nerves
         <strong>
          decreases
         </strong>
         the SA nodal pacemaker and is the dominant input at rest, while sympathetic nerve input, as well as the adrenal medullary release of catecholamines,
         <strong>
          increase
         </strong>
         the sinus rate during exercise and stress. (See
         <a class="local">
          'Autonomic nervous system and the SA node'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Sinus node dysfunction (SND) is characterized by dysfunction of the SA node that is often secondary to senescence of the SA node and surrounding atrial myocardium. Medications may also contribute and can often unmask subclinical sinoatrial dysfunction. (See
         <a class="local">
          'Definition'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/896.html" rel="external">
          "Sinus node dysfunction: Clinical manifestations, diagnosis, and evaluation", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – The epidemiology of SND is difficult to study, given the nature of SND and its varying manifestations, but patients with symptomatic SND are generally older (ie, seventh or eighth decade of life) with frequent comorbid diseases.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Causes
         </strong>
         – SA node dysfunction occurs as a result of disorders in automaticity, conduction, or both. Sinus node fibrosis is the most common cause of SND, although medications and toxins as well as systemic diseases that involve the heart can also be responsible for abnormal SA node function and result in SND. (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Natural history
         </strong>
         – The natural history of SND caused by sinus node fibrosis typically involves intermittent but progressive cardiac rhythm disorders, which have been associated with higher rates of other cardiovascular events and higher mortality. There is a tendency for the rhythm disturbances associated with SND to evolve over time, along with a higher likelihood of thromboembolic events and other cardiovascular events. (See
         <a class="local">
          'Natural history'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H903885301">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Alan Cheng, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Keith A, Flack M. The Form and Nature of the Muscular Connections between the Primary Divisions of the Vertebrate Heart. J Anat Physiol 1907; 41:172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bleeker WK, Mackaay AJ, Masson-Pévet M, et al. Functional and morphological organization of the rabbit sinus node. Circ Res 1980; 46:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyett MR, Honjo H, Kodama I. The sinoatrial node, a heterogeneous pacemaker structure. Cardiovasc Res 2000; 47:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyett MR, Dobrzynski H, Lancaster MK, et al. Sophisticated architecture is required for the sinoatrial node to perform its normal pacemaker function. J Cardiovasc Electrophysiol 2003; 14:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lakatta EG, Maltsev VA, Vinogradova TM. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker. Circ Res 2010; 106:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veldkamp MW, Wilders R, Baartscheer A, et al. Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families. Circ Res 2003; 92:976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuessler RB. Abnormal sinus node function in clinical arrhythmias. J Cardiovasc Electrophysiol 2003; 14:215.
          </a>
         </li>
         <li class="breakAll">
          Josephson, ME. Sinus Node Function. In: Clinical Cardiac Electrophysiology: Techniques and Interpretations, 4th, Lippincott, Williams, &amp; Wilkins, Philadelphia 2008. p.69-92.
         </li>
         <li class="breakAll">
          Pappano AJ, Mubagwa K. Actions of muscarinic agents and adenosine on the heart. In: The Heart and Cardiovascular System, Fozzard HA, et al (Eds), Raven Press, New York 1992. p.1765.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanders P, Morton JB, Davidson NC, et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 2003; 108:1461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morton JB, Sanders P, Vohra JK, et al. Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect. Circulation 2003; 107:1775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yanni J, Tellez JO, Maczewski M, et al. Changes in ion channel gene expression underlying heart failure-induced sinoatrial node dysfunction. Circ Heart Fail 2011; 4:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanders P, Kistler PM, Morton JB, et al. Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation 2004; 110:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hocini M, Sanders P, Deisenhofer I, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation 2003; 108:1172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sparks PB, Jayaprakash S, Vohra JK, Kalman JM. Electrical remodeling of the atria associated with paroxysmal and chronic atrial flutter. Circulation 2000; 102:1807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daoud EG, Weiss R, Augostini RS, et al. Remodeling of sinus node function after catheter ablation of right atrial flutter. J Cardiovasc Electrophysiol 2002; 13:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hadian D, Zipes DP, Olgin JE, Miller JM. Short-term rapid atrial pacing produces electrical remodeling of sinus node function in humans. J Cardiovasc Electrophysiol 2002; 13:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sparks PB, Mond HG, Vohra JK, et al. Electrical remodeling of the atria following loss of atrioventricular synchrony: a long-term study in humans. Circulation 1999; 100:1894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrer MI. The sick sinus syndrome in atrial disease. JAMA 1968; 206:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967; 29:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 2007; 115:1921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen PN, Gronroos NN, Chen LY, et al. Incidence of and risk factors for sick sinus syndrome in the general population. J Am Coll Cardiol 2014; 64:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000; 342:1385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994; 344:1523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan BM, Langendorf R, Lev M, Pick A. Tachycardia-bradycardia syndrome (so-called "sick sinus syndrome"). Pathology, mechanisms and treatment. Am J Cardiol 1973; 31:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thery C, Gosselin B, Lekieffre J, Warembourg H. Pathology of sinoatrial node. Correlations with electrocardiographic findings in 111 patients. Am Heart J 1977; 93:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           HUDSON RE. The human pacemaker and its pathology. Br Heart J 1960; 22:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Margolis JR, Strauss HC, Miller HC, et al. Digitalis and the sick sinus syndrome. Clinical and electrophysiologic documentation of severe toxic effect on sinus node function. Circulation 1975; 52:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strauss HC, Gilbert M, Svenson RH, et al. Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction. Circulation 1976; 54:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breithardt G, Seipel L, Wiebringhaus E, Loogen F. Effects of verapamil on sinus node function in man. Eur J Cardiol 1978; 8:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vera Z, Awan NA, Mason DT. Assessment of oral quinidine effects on sinus node function in sick sinus syndrome patients. Am Heart J 1982; 103:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LaBarre A, Strauss HC, Scheinman MM, et al. Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction. Circulation 1979; 59:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HG, Friedman HS. Procainamide-induced sinus node dysfunction in patients with chronic renal failure. Chest 1979; 76:699.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weintraub M, Hes JP, Rotmensch HH, et al. Extreme sinus bradycardia associated with lithium therapy. Isr J Med Sci 1983; 19:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thormann J, Neuss H, Schlepper M, Mitrovic V. Effects of clonidine on sinus node function in man. Chest 1981; 80:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lennerz C, Jilek C, Semmler V, et al. Sinus arrest from mad honey disease. Ann Intern Med 2012; 157:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yabek SM, Jarmakani JM. Sinus node dysfunction in children, adolescents, and young adults. Pediatrics 1978; 61:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hayes CJ, Gersony WM. Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study. J Am Coll Cardiol 1986; 7:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beder SD, Gillette PC, Garson A Jr, et al. Symptomatic sick sinus syndrome in children and adolescents as the only manifestation of cardiac abnormality or associated with unoperated congenital heart disease. Am J Cardiol 1983; 51:1133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenwood RD, Rosenthal A, Sloss LJ, et al. Sick sinus syndrome after surgery for congenital heart disease. Circulation 1975; 52:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benson DW, Wang DW, Dyment M, et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J Clin Invest 2003; 112:1019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caralis DG, Varghese PJ. Familial sinoatrial node dysfunction. Increased vagal tone a possible aetiology. Br Heart J 1976; 38:951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bharati S, Surawicz B, Vidaillet HJ Jr, Lev M. Familial congenital sinus rhythm anomalies: clinical and pathological correlations. Pacing Clin Electrophysiol 1992; 15:1720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Makiyama T, Akao M, Tsuji K, et al. High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations. J Am Coll Cardiol 2005; 46:2100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schulze-Bahr E, Neu A, Friederich P, et al. Pacemaker channel dysfunction in a patient with sinus node disease. J Clin Invest 2003; 111:1537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ueda K, Nakamura K, Hayashi T, et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J Biol Chem 2004; 279:27194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milanesi R, Baruscotti M, Gnecchi-Ruscone T, DiFrancesco D. Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel. N Engl J Med 2006; 354:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nof E, Luria D, Brass D, et al. Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation 2007; 116:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James TN. The sinus node. Am J Cardiol 1977; 40:965.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           James TN, Birk RE. Pathology of the cardiac conduction system in polyarteritis nodosa. Arch Intern Med 1966; 117:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           JAMES TN, RUPE CE, MONTO RW. PATHOLOGY OF THE CARDIAC CONDUCTION SYSTEM IN SYSTEMIC LUPUS ERYTHEMATOSUS. Ann Intern Med 1965; 63:402.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hatle L, Bathen J, Rokseth R. Sinoatrial disease in acute myocardial infarction. Long-term prognosis. Br Heart J 1976; 38:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rokseth R, Hatle L. Sinus arrest in acute myocardial infarction. Br Heart J 1971; 33:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simonsen E, Nielsen BL, Nielsen JS. Sinus node dysfunction in acute myocardial infarction. Acta Med Scand 1980; 208:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alboni P, Baggioni GF, Scarfò S, et al. Role of sinus node artery disease in sick sinus syndrome in inferior wall acute myocardial infarction. Am J Cardiol 1991; 67:1180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puljiz I, Beus A, Kuzman I, Seiwerth S. Electrocardiographic changes and myocarditis in trichinellosis: a retrospective study of 154 patients. Ann Trop Med Parasitol 2005; 99:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Assimakopoulos SF, Michalopoulou S, Papakonstantinou C, et al. A case of severe sinus bradycardia complicating anicteric leptospirosis. Am J Med Sci 2007; 333:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cunha BA, Thermidor M, Mohan S, et al. Fever of unknown origin: subacute thyroiditis versus typhoid fever. Heart Lung 2005; 34:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clin Microbiol Infect 2000; 6:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lien WP, Lee YS, Chang FZ, et al. The sick sinus syndrome: natural history of dysfunction of the sinoatrial node. Chest 1977; 72:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           John RM, Kumar S. Sinus Node and Atrial Arrhythmias. Circulation 2016; 133:1892.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrer MI. The etiology and natural history of sinus node disorders. Arch Intern Med 1982; 142:371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simonsen E, Nielsen JS, Nielsen BL. Sinus node dysfunction in 128 patients. A retrospective study with follow-up. Acta Med Scand 1980; 208:343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandt J, Anderson H, Fåhraeus T, Schüller H. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol 1992; 20:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Menozzi C, Brignole M, Alboni P, et al. The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome. Am J Cardiol 1998; 82:1205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen HR, Nielsen JC, Thomsen PE, et al. Arterial thromboembolism in patients with sick sinus syndrome: prediction from pacing mode, atrial fibrillation, and echocardiographic findings. Heart 1999; 81:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alonso A, Jensen PN, Lopez FL, et al. Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities study and Cardiovascular Health Study. PLoS One 2014; 9:e109662.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 940 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17232727" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The Form and Nature of the Muscular Connections between the Primary Divisions of the Vertebrate Heart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7349910" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Functional and morphological organization of the rabbit sinus node.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10974216" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The sinoatrial node, a heterogeneous pacemaker structure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12625620" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Sophisticated architecture is required for the sinoatrial node to perform its normal pacemaker function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20203315" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart's pacemaker.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12676817" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12693509" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Abnormal sinus node function in clinical arrhythmias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12693509" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Abnormal sinus node function in clinical arrhythmias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12693509" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Abnormal sinus node function in clinical arrhythmias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12952837" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12665497" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21565973" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Changes in ion channel gene expression underlying heart failure-induced sinoatrial node dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15302799" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12952840" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11023936" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Electrical remodeling of the atria associated with paroxysmal and chronic atrial flutter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11843478" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Remodeling of sinus node function after catheter ablation of right atrial flutter.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12108502" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Short-term rapid atrial pacing produces electrical remodeling of sinus node function in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10545434" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Electrical remodeling of the atria following loss of atrioventricular synchrony: a long-term study in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5695590" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The sick sinus syndrome in atrial disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6029120" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Electrical reversion of cardiac arrhythmias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17420362" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : New insights into pacemaker activity: promoting understanding of sick sinus syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25104519" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Incidence of and risk factors for sick sinus syndrome in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12063369" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10805823" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7983951" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4692587" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Tachycardia-bradycardia syndrome (so-called "sick sinus syndrome"). Pathology, mechanisms and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/871100" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Pathology of sinoatrial node. Correlations with electrocardiographic findings in 111 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14403753" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The human pacemaker and its pathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1132120" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Digitalis and the sick sinus syndrome. Clinical and electrophysiologic documentation of severe toxic effect on sinus node function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/947574" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/710495" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Effects of verapamil on sinus node function in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7055049" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Assessment of oral quinidine effects on sinus node function in sick sinus syndrome patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/758990" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/92391" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Procainamide-induced sinus node dysfunction in patients with chronic renal failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6406388" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Extreme sinus bradycardia associated with lithium therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7018848" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Effects of clonidine on sinus node function in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23165673" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Sinus arrest from mad honey disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/662485" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Sinus node dysfunction in children, adolescents, and young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3941200" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Arrhythmias after the Mustard operation for transposition of the great arteries: a long-term study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6837459" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Symptomatic sick sinus syndrome in children and adolescents as the only manifestation of cardiac abnormality or associated with unoperated congenital heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1149204" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Sick sinus syndrome after surgery for congenital heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14523039" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/971377" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Familial sinoatrial node dysfunction. Increased vagal tone a possible aetiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1279540" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Familial congenital sinus rhythm anomalies: clinical and pathological correlations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16325048" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : High risk for bradyarrhythmic complications in patients with Brugada syndrome caused by SCN5A gene mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12750403" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Pacemaker channel dysfunction in a patient with sinus node disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15123648" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16407510" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17646576" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/930844" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The sinus node.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4379409" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Pathology of the cardiac conduction system in polyarteritis nodosa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14327506" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : PATHOLOGY OF THE CARDIAC CONDUCTION SYSTEM IN SYSTEMIC LUPUS ERYTHEMATOSUS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1267985" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Sinoatrial disease in acute myocardial infarction. Long-term prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5115008" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Sinus arrest in acute myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7468315" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Sinus node dysfunction in acute myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2035437" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Role of sinus node artery disease in sick sinus syndrome in inferior wall acute myocardial infarction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15949188" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Electrocardiographic changes and myocarditis in trichinellosis: a retrospective study of 154 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17570992" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : A case of severe sinus bradycardia complicating anicteric leptospirosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15761461" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Fever of unknown origin: subacute thyroiditis versus typhoid fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11284920" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The diagnostic significance of relative bradycardia in infectious disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/913143" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : The sick sinus syndrome: natural history of dysfunction of the sinoatrial node.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27166347" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Sinus Node and Atrial Arrhythmias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7059261" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : The etiology and natural history of sinus node disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7457202" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Sinus node dysfunction in 128 patients. A retrospective study with follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1512343" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9832095" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The natural course of untreated sick sinus syndrome and identification of the variables predictive of unfavorable outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10092569" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Arterial thromboembolism in patients with sick sinus syndrome: prediction from pacing mode, atrial fibrillation, and echocardiographic findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25285853" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities study and Cardiovascular Health Study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
